GHP Q1 2024- Cover

Q1 2024

Welcome to the Q1 2024 edition of Global Health & Pharma magazine, providing you with all of the latest news and features across the healthcare and pharmaceutical landscape.

Over the last year, we have seen significant breakthroughs in vaccine development, cancer treatments, GLP-1 drugs revolutionising obesity management, gene therapy and gene editing technology for rare diseases, treatments for complex diseases such as Alzheimer’s, and drugs for a spectrum of conditions including migraines, menopausal symptoms, and post-partum depression.

Indeed, 2023 was a year of great innovation and success and 2024 looks to take this to the next level, with the sector being expected to continue to grow and thrive. Artificial intelligence will remain a key contributor to the driving of new drug discovery and development. Rapid uptake in AI technology has been accelerating the identifying of new drug candidates, reducing the hefty cost that comes with drug development, and improving the success rate of drug trials. Further, AI has the potential to help the sector meet increasing demand for personalised medicine and precision therapies by analysing patient responses to treatment.

Now, we invite you to explore the stories of our award-winning businesses who have each been playing their own part in the progress of the health and pharmaceutical industry around the world, whether they specialise in stem cell and auto-transfusion solutions, drug development, assisted reproductive technology (ART), pharmaceutical consulting for other businesses, and more.

We hope you find this issue to be informative and inspiring, and we look forward to welcoming you back again soon for our Q2 issue.

Q4 2023

Welcome to the Q4 2023 edition of Global Health & Pharma magazine, providing you with all of the latest news and features across the healthcare and pharmaceutical landscape.

As 2023 nears its end, it becomes a very fitting time to take a look back at the last 12 months and how the industry has continued to thrive. Medtech remains a very prominent concept, with organisations harnessing the power of cutting-edge technology to do incredible things.

For starters, on our front cover, we’re pleased to feature the revolutionary OmniAb, our Best Therapeutic Antibody Discover Company 2023 – USA. Pushing the boundaries of therapeutic antibody discovery, OmniAb provides its pharmaceutical partners with the most diverse antibody repertoires and state-of-the-art screening technologies to facilitate the discovery of next-generation therapeutics.

Elsewhere, we’re keen to promote how advancing tech has made rapid urine tests for HPV possible, an alternative method to cervical screening. A less invasive way of collecting cervical cell samples, this solution would be the ideal alternative for those who don’t wish to attend cervical screenings, in turn, saving more lives.

From there, we showcase more of our award-winning firms who are also providing highly innovative solutions, whether food sensitivity and intolerance tests, prognostic diabetic biomarkers, PEMF therapy mats and devices, clinical skincare, luxury dental experiences, and many more. We also shine a light on outstanding organisations who are delivering crucial services in mental health treatment and eating disorder recovery care.

I hope you find this issue to be informative and insightful, the GHP team wishes you a wonderful end to 2023 and the most prosperous quarter ahead. In the meantime, we look forward to welcoming you back again in Q1 2024.

Q3 2023

Welcome to the Q3 2023 edition of Global Health & Pharma magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

So far, 2023 has been an incredibly prosperous year for the health and pharma industry. As always, we’re delighted to be showcasing some the extraordinary organisations who are making this the case, with our award winners including the best of the best. Take a look through these pages to explore the most innovative and dedicated companies, whether they specialise in Point of Care Testing, clinical trial solutions, pharmaceutical clinical research, laser skin health, infection prevention solutions, and more.

On our front cover we feature ICROM, our Best Active Pharmaceutical Ingredients Manufacturer 2023 – Italy, led by CEO, Pierfrancesco Morosini. We gain an exciting insight into the company’s chemical-pharmaceutical manufacturing services and its devotion to providing only the highest of standards for its customers and their patients. ICROM boasts five decades of experience, with a team whose extensive know-how enables them to build high-tech solutions to create complex molecules.

I hope you enjoy perusing this issue and find each of our award-winning business’ stories to be inspirational and insightful. All of us at GHP wish you a wonderful quarter ahead and look forward to welcoming you back again in Q4.

Rebecca Scotland, Editor
Website: www.ghp-news.com

Q2 2023

Welcome to the Q2 edition of Global Health & Pharma Magazine 2023, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

As we find ourselves half way through the year already, we have so many exciting developments to share with you. In this issue, we’re pleased to be featuring an array of innovative companies delivering cutting-edge solutions for healthcare providers, whether practice management software, an orthopaedic medical device, or healthcare informatics digital platform. Each is designed to enable the utmost efficiency and an excellent experience for patients.

Then there are those outstanding companies providing services and products for individuals who need them, such as online mindfulness training, home care, dental treatments, earwax removal, skincare, as well as a nutritional drink supplement, all developed to contribute to the best quality of life possible.

And on our front cover, we’re delighted to be featuring Dynamic DNA Laboratories, who we’ve named as Best Supplier of At-Home DNA Testing Kits. Operating within its hi-tech genetics, microbiology, cellular, and microscopy laboratory, the Dynamic DNA team specialise in advanced DNA testing and strive to promote positive change by helping people better understand themselves.

All it takes is a cheek swab and the company can help you learn more about your ancestry and health by analysing your genetic code.

We hope you find this issue to be informative and insightful and wish you a prosperous quarter ahead. In the meantime, we looking forward to welcoming you back again for Q3 issue.

Q1 2023

Welcome to the Q1 2023 edition of Global Health & Pharma magazine, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

As I write this, there are 23 days left of Q1 and 2023 is already proving to be a year of great prosperity, but also continuous change for the healthcare and pharmaceutical industry. Experts are poised for what is to come and how to adapt in order to keep innovating and thriving, whether it’s ensuring access to and savviness in using the latest technologies, making the most of new research, keeping clinical trials moving along, or meeting the shifting needs of customers and patients.

In this issue of GHP, we are excited to be showcasing an array of cutting-edge health and pharma businesses that are truly flourishing – and it’s because they know how to stay ahead of the curve. Varicose veins treatment clinics, aesthetics clinics, dental practices, and hair transplant providers make it their mission to improve quality of life for individuals, while clinical diagnostic testing laboratories, medical device consulting firms, and healthcare marketing agencies exist to bolster the offering of fellow health companies. Whatever the part these businesses play in this fast-paced industry, they’re making a crucial contribution.

We hope you find reading through this issue to be informative and inspiring, and we look forward to welcoming you back for our Q2 issue.

Q4 2022

Welcome to the Q4 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

There’s no denying how the health and pharma industry is one of the most innovative in the world, having over the past century played such a crucial role in the development of new and improved medicines to prevent and treat diseases, as well as enhance quality of life for so many. This unique, thriving industry continues to revolutionise healthcare by helping to tackle unmet medical needs.

An example of a company doing just this is our cover feature, Elucent Medical, who deliver ground-breaking solutions that enable surgeons to provide individualised patient care, no matter how simple or complex, with great efficiency and effectiveness. It is an extraordinary company that continues to evolve and redefine the standards of care to improve patient lives, and we are delighted to be giving you an insight into its work.

Overall, we are proud to bestow our awards upon a myriad of cutting-edge businesses as they end 2022 on a high. All of us at GHP wish you a restful and reflective festive season and a prosperous new year. We look forward to welcoming you back again for the Q1 issue.

Q3 2022

Welcome to the Q3 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

Global health and pharmaceuticals is an extremely important part of our world. As we continue to grow and improve, we are quickly advancing scientifically. The only difficulty is that industries need to keep up with these changes. By using the most intricate, pioneering, relevant, and cutting-edge technologies and methods, we are able to focus in on making the world a healthier – and therefore happier – place for all.

This issue showcases a selection of businesses that work with clinical trials, AI technology, and much more to provide excellent healthcare services. With the population growing, there is a bigger need to evolve. In this way, it is obvious that these companies are contributing to this new age of scientific development for the greatest outcome in healthcare services. With smart solutions and helpful equipment, anything is possible.

We are proud to present these ground-breaking businesses as they win a plethora of enviable awards. All of us at GHP hope you have a tremendous quarter ahead. We look forward to welcoming you back again for Q4 this year.

Q2 2022

Welcome to the Q2 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

We are always in need of scientific developments. With a plethora of diseases, conditions, and medical issues in general, we require the rapid progress of remedies and cures. From medicine to devices, the most important thing is that we become more vigilant and resilient with our inventions, preventions, and ways of living our lives.

In this issue we explore some practices, firms, and companies that are using their sheer intellect and highly professional attitude to change the medical sphere. From innovative dental care to intricate surgery, medical device development to exceptional biotechnology, and much more, this issue of GHP is looking at a variety of businesses that are altering the way we see healthcare and medicine as a whole.

All of us at GHP wish you very prosperous and fulfilling times ahead and we look forward to delivering Q3 to you soon.

Q1 2022

Welcome to the Q1 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape.

With tensions continuing to build around the globe, we can see an influx of individuals and businesses that promote togetherness. Here we can see the building blocks to a better future in health and research to overcome some of life’s greatest challenges.

It is this togetherness that ensures safe spaces for people everywhere – mentally, physically, and emotionally. We experience these medical developments in a way that changes our perception of good health as well as our relationships with our bodies.

In this issue we see the present and future of testing, holistic wellness, luxury training facilities, nutritional ingredient solutions, and much more. With skilled and revolutionary clinics that are leaders in their industry; we open, continue, and finish strong throughout this entire issue.

These excellent success stories show us more beneficial treatments and health services than ever before. We have been in touch with many companies, across an assortment of sectors, that are researching and enforcing new ways of curing, testing, and supporting people all over the world.

For example, The Whiteley Clinic’s treatments in the field of phlebology has propelled it to a point of great success. With its blood research abilities and passion, it has been changing the course of healthcare.

As spring swiftly approaches us, we at GHP wish you a very happy March. We look forward to seeing you again for Q2.

Q4 2021

Welcome to the 2021 Q4 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

The last couple of years have witnessed a wide variety of businesses, across multiple industries, flourish and thrive even in the face of adversity. However, here we can see a selection of particularly innovative and focused businesses that have astonishingly excelled throughout the global pandemic.

For instance, our cover company Smart Blood Analytics have introduced two fine products that have altered the way we diagnose illnesses. This experienced Swiss business harnesses the power of Artificial Intelligence to detect any current or future defects within the blood. This is an invaluable service that can ultimately conquer the late diagnosis of serious illness and disease. With developments like this we can look towards the future with confidence.

Join us as we delve deeper into many other successful business stories that have not only stood the test of time, but that have grown exponentially throughout some of the darkest days. As usual, we hope you enjoy this issue and we look forward to seeing you again for Q1 2022.

Q3 2021

Welcome to the 2021 Q3 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

As we come towards the final quarter of a second year shaped by a global pandemic, we might be excused for thinking only on the exceptional work around Covid-19 when reflecting on the successes achieved by the healthcare and pharmaceutical industries this year. However, over the last quarter, the global companies within these vital sectors have remained just as – if not more – busy with endeavours outside the pandemic as well.

From the development of lasers and their expanding capabilities being championed by our cover company for this month, Erchonia Lasers, to the ground-breaking personalisation technology within breast cancer treatment being developed by DCISionRT, to the many other stories of exceptional and transformational work exhibited in this issue of GHP Magazine, it is clear that the global health and pharmaceutical industry has a lot to be proud of this quarter.

Thus, we invite you to dive in and discover more about these fantastic companies and their life-changing work – whether it be in aesthetic treatments or surgical procedures, pharmaceutical innovations or the enhanced services. We hope you enjoy this issue of GHP Magazine, and wish you safe and well until we meet again in the Q4 edition.

Q2 2021

Welcome to the 2021 Q2 edition of Global Health & Pharma Magazine, providing you with all the latest news and features from across the healthcare and pharmaceutical landscape.

While the last eighteen months have seen all industries demonstrating resilience and versatility in a period defined by adversity, few have matched the exceptional work of the global healthcare and pharmaceutical industries. These impressive feats are by no means limited to successful vaccine programme rollouts or treatment of Covid-19 cases – as individuals have become more aware of the importance of caring for our general physical and mental wellbeing during the pandemic, organisations across the industry have seen demand for their products and services soar.

That is certainly the case for the companies included in this quarter’s edition of GHP, including our cover company, BioMin Technologies, a leading researcher into dental sensitivity and developer of sensitivity relief and prevention products. We find out how this London-based start-up has grown since 2015 and plans to build on the momentum generated in online sales during the pandemic to see further growth that facilitates exciting advanced research into dental sensitivities.

Join us as we explore many of the other success stories to come out of this vibrant and valued industry over the past few months. Until the next issue of GHP, we wish you all the best for the months ahead.